We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$517M
AUM Growth
+$9.2M
Cap. Flow
+$14.4M
Cap. Flow %
2.78%
Top 10 Hldgs %
25.19%
Holding
131
New
22
Increased
34
Reduced
42
Closed
11
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
51
Thermo Fisher Scientific
TMO
$213B
$4.39M 0.85%
7,965
+2,125
+36% +$1.13M
KRTX
52
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.29M 0.83%
21,810
+2,500
+13% +$536K
TMCI icon
53
Treace Medical Concepts
TMCI
$280M
$4.14M 0.8%
179,924
-63,750
-26% -$1.47M
RLYB icon
54
Rallybio
RLYB
$84.5M
$4.07M 0.79%
77,486
+48,313
+166% +$2.85M
ZNTL icon
55
Zentalis Pharmaceuticals
ZNTL
$337M
$4.05M 0.78%
201,000
+141,000
+235% +$3.03M
IMGN
56
DELISTED
Immunogen Inc
IMGN
$3.99M 0.77%
803,944
-44,800
-5% -$243K
ARWR icon
57
Arrowhead Research
ARWR
$11.9B
$3.87M 0.75%
95,400
-3,400
-3% -$113K
CYTK icon
58
Cytokinetics
CYTK
$10.5B
$3.82M 0.74%
83,450
RCKT icon
59
Rocket Pharmaceuticals
RCKT
$340M
$3.73M 0.72%
190,790
-80,000
-30% -$1.47M
BIIB icon
60
Biogen
BIIB
$30B
$3.7M 0.72%
13,352
+100
+0.8% +$28.2K
OM icon
61
Outset Medical
OM
$84.7M
$3.61M 0.7%
9,333
+6,000
+180% +$1.69M
BMY icon
62
Bristol-Myers Squibb
BMY
$133B
$3.6M 0.7%
50,000
-15,500
-24% -$1.17M
OLMA icon
63
Olema Pharmaceuticals
OLMA
$1B
$3.53M 0.68%
1,441,805
+558,749
+63% +$1.63M
ABT icon
64
Abbott
ABT
$183B
$3.49M 0.67%
31,748
-20,000
-39% -$2.07M
MRNA icon
65
Moderna
MRNA
$21.8B
$3.18M 0.62%
17,718
-575
-3% -$94K
IQV icon
66
IQVIA
IQV
$38.7B
$3.09M 0.6%
15,100
-5,200
-26% -$1.05M
DHR icon
67
Danaher
DHR
$137B
$3.09M 0.6%
13,113
+3,384
+35% +$784K
MRTX
68
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.03M 0.59%
66,846
+7,330
+12% +$474K
ARQT icon
69
Arcutis Biotherapeutics
ARQT
$3.36B
$3.02M 0.58%
203,852
-17,133
-8% -$299K
PCVX icon
70
Vaxcyte
PCVX
$7.81B
$2.88M 0.56%
+60,000
New +$2.35M
NTLA icon
71
Intellia Therapeutics
NTLA
$1.49B
$2.49M 0.48%
71,380
BEAM icon
72
Beam Therapeutics
BEAM
$2.63B
$2.48M 0.48%
63,500
-2,200
-3% -$98.5K
GRTX
73
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.48M 0.48%
+1,666,666
New +$2.7M
MDT icon
74
Medtronic
MDT
$109B
$2.45M 0.47%
31,551
EW icon
75
Edwards Lifesciences
EW
$49.6B
$2.38M 0.46%
+31,900
New +$2.46M

Similar funds

Sectoral Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Sectoral Asset Management held 131 positions worth $517M, up 1.8% from $508M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sectoral Asset Management's Q4 2022 filing shows 22 new, 34 increased, 42 reduced and 11 closed positions. Its largest new stake was Option Care Health: 273,500 shares worth $8.23M. The largest sale was Syneos Health, Inc. Class A Common Stock, an estimated $8.62M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q4 2022 buy was Option Care Health: 273,500 shares worth $8.23M.
  • Sectoral Asset Management added most to R1 RCM Inc. Common Stock in Q4 2022, an estimated $8.5M increase.
  • Sectoral Asset Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $7.28M.
  • Sectoral Asset Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2022, selling an estimated $8.62M.
  • Sectoral Asset Management's ten largest holdings make up 25% of its $517M portfolio in Q4 2022.
  • Sectoral Asset Management opened 22 new positions and closed 11 in Q4 2022.
  • Sectoral Asset Management's portfolio value rose 1.8% quarter-over-quarter to $517M.

Based on Sectoral Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.